Why I wouldn't touch Novavax with a 10-foot pole

Novavax (NASDAQ: NVAX) was once a leading contender to dominate the coronavirus vaccine market. The company faced several challenges, however, and although it successfully launched its vaccine, ...
abc7NY

COVID News: Novavax says its vaccine could win over skeptics

NEW YORK (WABC) -- The biotechnology company Novavax plans to submit complete data to the US Food and Drug Administration soon for possible emergency use authorization of its coronavirus vaccine ...
kristv

Novavax requests FDA authorization for its COVID-19 vaccine

There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization ...
ksby

FDA authorizes Novavax's protein-based COVID-19 vaccine

The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older. The Novavax vaccine ...
fox13now

Novavax says its COVID-19 vaccine is effective in children as young as 12

Novavax says its COVID-19 vaccine is proving safe and effective for kids as young as 12. The Maryland-based company makes a protein-based vaccine that's been cleared for use in adults in parts ...
Taipei Times

COVID-19 vaccine program to cover all residents

The government-funded COVID-19 vaccination program is from Jan. 1 to Feb. 28 next year to be expanded to cover all residents ...
Scientific American

Scientists Explain How mRNA COVID Vaccines May Rarely Cause Myocarditis

A new study identifies a mechanism for how COVID vaccines may, in infrequent cases, drive heart inflammation, a condition ...
Nature

Five years of COVID vaccines: how a breakthrough created a public-health crisis

Physician and science communicator Kristen Panthagani talks about why public trust in vaccines has fallen since the COVID-19 ...